Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sesen Bio Inc
(NQ:
SESN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sesen Bio Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
SHAREHOLDER ALERT: BZ DIDI SESN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
August 23, 2021
NEW YORK, NY / ACCESSWIRE / August 23, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...
From
The Law Offices of Vincent Wong
Via
AccessWire
Topics
Fraud
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
SESEN SHAREHOLDER ALERT
August 22, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SESEN DEADLINE ALERT
August 21, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SESEN BIO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Sesen Bio, Inc. and Encourages Investors to Contact the Firm
August 20, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Sesen Bio, Inc. (SESN) Investors
August 20, 2021
From
Kirby McInerney LLP
Via
Business Wire
SESN ALERT: Investors With Substantial Losses Have Opportunity to Lead the Sesen Bio, Inc. Class Action Lawsuit
August 20, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Sesen Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 20, 2021
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Sesen Bio, Inc. (SESN) Investors
August 20, 2021
From
Law Offices of Howard G. Smith
Via
Business Wire
SESN CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Sesen Bio, Inc.
August 20, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
SESN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Sesen Bio, Inc.
August 19, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
SESEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Sesen Bio, Inc. on Behalf of Sesen Stockholders and Encourages Investors to Contact the Firm
August 19, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Sesen Bio, Inc. (SESN) on Behalf of Investors
August 19, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
Lost Money in Sesen Bio, Inc.?
August 19, 2021
From
Gibbs Law Group
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Sesen Bio, Inc. (SESN) on Behalf of Investors
August 19, 2021
From
Law Offices of Howard G. Smith
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Sesen Bio, Inc. Investors with Losses to Inquire About Class Action Investigation – SESN
August 19, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Sesen Bio, Inc. (SESN) on Behalf of Investors
August 18, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Sesen Bio, Inc. (SESN) on Behalf of Investors
August 18, 2021
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Sesen Bio, Inc. (SESN) on Behalf of Investors
August 18, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Federman & Sherwood Announces an Investigation into Sesen Bio
August 17, 2021
From
Federman & Sherwood
Via
Business Wire
Sesen Bio Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs)
August 13, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Strengthens Executive Leadership Team as the Company Approaches the Potential Approval and Commercial Launch of Vicineum™
August 11, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Reports Second Quarter 2021 Financial Results and Significant Global Progress for Vicineum™
August 09, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Announces Partnership with Eczacibasi Pharmaceuticals Marketing (EIP) for the Commercialization of Vicineum™ in Turkey
August 05, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Strengthens Leadership Team as the Company Approaches the Potential Approval and Launch of Vicineum™
August 02, 2021
From
Sesen Bio, Inc.
Via
Business Wire
Sesen Bio Announces Significant Commercial Progress as the Company Approaches the Potential Approval and Launch of Vicineum™ in the US
July 26, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Announces New Appointments to its Board of Directors
July 21, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio and Qilu Pharmaceutical Announce Enrollment of First Patient in Clinical Trial for Vicineum™ in China
July 20, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Announces Productive Late-Cycle Meeting with the FDA for Vicineum™
July 14, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2021
From
Sesen Bio
Via
Business Wire
Sesen Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2021
From
Sesen Bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.